Floatz logo

Azathioprine

Autoimmune Hepatitis

Xiaoli FanSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

2 Active assets in the Autoimmune Hepatitis cohort.

Asset / SponsorPhaseRating
URSODEOXYCHOLIC ACID
West China Hospital
Phase 4BB
CYCLOSPORIN A
West China Hospital
Phase 4B
Jkb-122
TaiwanJ Pharmaceuticals Co., Ltd
Phase 2CCC
Orbcel-C
University of Birmingham
Phase 1/2CCC
Siplizumab
Elizabeth C. Verna
Phase 1C
METRONIDAZOLE
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
N/AD
Budesonide
Mayo Clinic
N/AD

Same molecule, other indications

Azathioprine is also rated in:

primary biliary cholangitisDormant
BB
Indicative ·
65 / 100
View asset →
hepatocellular carcinomaDormant
B
Indicative ·
62 / 100
View asset →
pulmonary fibrosisDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →